{"id":"https://openalex.org/W4361891706","doi":"https://doi.org/10.1158/1078-0432.22487252","title":"Supplementary Data from Selinexor Combined with Ibrutinib Demonstrates Tolerability and Safety in Advanced B-Cell Malignancies: A Phase I Study","display_name":"Supplementary Data from Selinexor Combined with Ibrutinib Demonstrates Tolerability and Safety in Advanced B-Cell Malignancies: A Phase I Study","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361891706","doi":"https://doi.org/10.1158/1078-0432.22487252"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.22487252","doi":"https://doi.org/10.1158/1078-0432.22487252","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22487252","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.22487252","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031412066","display_name":"Deborah Marie Stephens","orcid":"https://orcid.org/0000-0001-9188-5008","observed_orcids":["https://orcid.org/0000-0001-9188-5008"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Deborah M. Stephens","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9188-5008","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082021894","display_name":"Ying Huang","orcid":"https://orcid.org/0000-0001-9910-1212","observed_orcids":["https://orcid.org/0000-0001-9910-1212","https://orcid.org/0009-0002-6227-4755"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ying Huang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9910-1212","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109829305","display_name":"Amy S. Ruppert","orcid":"https://orcid.org/0000-0001-9612-6473","observed_orcids":["https://orcid.org/0000-0001-9612-6473"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amy S. Ruppert","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063266976","display_name":"Janek S. Walker","orcid":"https://orcid.org/0000-0002-2049-1527","observed_orcids":["https://orcid.org/0000-0002-2049-1527"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Janek S. Walker","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2049-1527","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019455562","display_name":"Daniel Canfield","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel Canfield","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028386076","display_name":"Casey B. Cempre","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Casey B. Cempre","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050220993","display_name":"Qiang Fu","orcid":"https://orcid.org/0000-0001-7136-5849","observed_orcids":["https://orcid.org/0000-0001-7136-5849"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Qiang Fu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077260725","display_name":"Sharyn D. Baker","orcid":"https://orcid.org/0000-0003-3062-3252","observed_orcids":["https://orcid.org/0000-0003-3062-3252"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sharyn Baker","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3062-3252","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024273516","display_name":"Boyu Hu","orcid":"https://orcid.org/0000-0001-9848-9497","observed_orcids":["https://orcid.org/0000-0001-9848-9497"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Boyu Hu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9848-9497","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011348837","display_name":"Harsh Shah","orcid":"https://orcid.org/0000-0001-6054-5238","observed_orcids":["https://orcid.org/0000-0001-6054-5238"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Harsh Shah","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079332929","display_name":"Renee Vadeboncoeur","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Renee Vadeboncoeur","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042260558","display_name":"Kerry Anne Rogers","orcid":"https://orcid.org/0000-0001-5748-7874","observed_orcids":["https://orcid.org/0000-0001-5748-7874"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kerry A. Rogers","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5748-7874","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050724356","display_name":"Seema Ali Bhat","orcid":"https://orcid.org/0000-0001-7844-0856","observed_orcids":["https://orcid.org/0000-0001-7844-0856"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Seema Bhat","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7844-0856","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072835425","display_name":"Samantha Mary Jaglowski","orcid":"https://orcid.org/0000-0002-4335-2554","observed_orcids":["https://orcid.org/0000-0002-4335-2554"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Samantha M. Jaglowski","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4335-2554","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078286506","display_name":"Hank A. Lockman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hank Lockman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023800287","display_name":"Rosa Lapalombella","orcid":"https://orcid.org/0000-0001-6916-9400","observed_orcids":["https://orcid.org/0000-0001-6916-9400"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rosa Lapalombella","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000921376","display_name":"John C. Byrd","orcid":"https://orcid.org/0000-0001-9830-0711","observed_orcids":["https://orcid.org/0000-0001-9830-0711"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John C. Byrd","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5014241029","display_name":"Jennifer Ann Woyach","orcid":"https://orcid.org/0000-0002-3403-9144","observed_orcids":["https://orcid.org/0000-0002-3403-9144"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jennifer A. Woyach","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.9824000000953674,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.9824000000953674,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.014499999582767487,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/selinexor","display_name":"selinexor","score":0.9990000128746033},{"id":"https://openalex.org/keywords/ibrutinib","display_name":"ibrutinib","score":0.9860000014305115},{"id":"https://openalex.org/keywords/b-cell-malignancies","display_name":"B-cell malignancies","score":0.800000011920929},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.5799999833106995},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.8100000023841858},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6740000247955322},{"id":"https://openalex.org/keywords/bruton-tyrosine-kinase-inhibitors","display_name":"BTK inhibitors","score":0.6629999876022339}],"concepts":[{"id":"https://openalex.org/C2779878957","wikidata":"https://www.wikidata.org/wiki/Q5984881","display_name":"Ibrutinib","level":4,"score":0.9458770751953125},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.8475894927978516},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.46865975856781006},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3663882613182068},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3210642635822296},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2665144205093384},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.2612955868244171},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.19570127129554749},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.07821199297904968}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1078-0432.22487252","doi":"https://doi.org/10.1158/1078-0432.22487252","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22487252","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.22487252","doi":"https://doi.org/10.1158/1078-0432.22487252","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22487252","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2988532607","https://openalex.org/W4281385652","https://openalex.org/W4361954034","https://openalex.org/W2055393972","https://openalex.org/W4401014880","https://openalex.org/W4249292799","https://openalex.org/W2746977721","https://openalex.org/W4282026745","https://openalex.org/W3088151338","https://openalex.org/W2979432543"],"abstract_inverted_index":{"Supplementary":[0],"Data":[1],"from":[2],"Selinexor":[3],"Combined":[4],"with":[5],"Ibrutinib":[6],"Demonstrates":[7],"Tolerability":[8],"and":[9],"Safety":[10],"in":[11],"Advanced":[12],"B-Cell":[13],"Malignancies:":[14],"A":[15],"Phase":[16],"I":[17],"Study":[18]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-05T00:00:00"}